Makers Labs Q1FY27: CEO Saahil Parikh steps down, standalone loss widens

Revenue DeclinePat NegativeResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.6%Reaction day

₹165.90

prior close

₹173.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%-3.6% vs market

Pharmaceuticals peers, median of 168sector+0.3%-3.8% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 3.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.0

10m

-7.6

15m

-8.6

30m

-9.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.6+0.0-3.6+0.3-3.8

Next day

-7.0-0.0-7.0+0.7-7.7

-2.0-0.2-1.9+0.6-2.6

-4.9+0.2-5.1+0.4-5.3

-7.8+0.3-8.1+1.2-9.0

-6.0+0.4-6.4+0.2-6.2

—+0.9—+0.2—

15d

—+1.6—+1.1—

—+2.0—+2.4—

—+0.6—+1.6—

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Makers Laboratories posted Q1FY27 standalone revenue of Rs 1,019 lacs, down about 10 percent from Rs 1,127 lacs a year ago. Standalone net loss widened to Rs 108 lacs from Rs 96 lacs. Consolidated revenue rose about 20 percent to Rs 4,277 lacs, driven by subsidiary Resonance Specialties, though consolidated PAT attributable to owners fell to Rs 109 lacs from Rs 150 lacs. CEO Saahil Parikh will not seek re-appointment as Whole-time Director and will move to a Non-Executive Director role from August 11, 2026. Auditors issued an unmodified limited review report.

Likely market impact

Mixed quarter: consolidated revenue up about 20 percent but PAT fell. Standalone shrank with widening losses. CEO transition is a key governance change to watch.